Amnion

Key Patents: US-9662257 | US-11679050 | EP-3370676 | JP-6755949

about Amniobed™

Our Mission

Revolutionizing Neonatal Care:

At Amnion Life, our mission is to revolutionize neonatal care by developing innovative solutions that enhance the survival and quality of life for preterm infants. We are dedicated to empowering healthcare professionals with advanced technology and providing families with hope through our commitment to safety, compassion, and groundbreaking research. By pushing the boundaries of what’s possible in neonatal care, we aim to make a lasting impact on the future of every newborn.”

The Storyof Amnion Life:

From Dream to Reality: The Birth of Amnion Life

Amir Fassihi’s journey to founding Amnion Life began with a deeply personal experience. His niece was born preterm and faced challenges, including hypothermia, that contributed to significant neurodevelopmental issues requiring lifelong care. Witnessing her struggles and the challenges faced by preterm infants left a profound impact on Amir. Shortly after, he had a vivid dream about a synthetic womb solution—a vision that became the catalyst for Amnion Life. With this dream as his guiding light, Amir set out to revolutionize neonatal care, driven by a mission to provide better outcomes for preterm infants and their families

Meet the team

Our Global Team

Highlight the key team members with headshots and short bios:

Amir Fassihi, M.D

Co-CEO and Founder

Dr. Amir Fassihi, a UCSF-trained radiologist, founded Amnion Life after a personal experience with a family member’s premature infant. This inspired the creation of the Amniobed™, designed to improve neonatal care by reducing hypothermia risks in preterm infants. Dr. Fassihi’s leadership has driven Amnion Life’s vision, including building a skilled engineering team as he remains dedicated to advancing neonatal care globally.

Frasier Glenn

Co-Founder and Co-CEO
Frasier Glenn leads strategic planning at Amnion Life, focusing on the upcoming launch of the Amniobed™. With a background in med tech consulting and a Master’s in Public Health, Frasier specializes in healthcare strategy, agile methodologies, and business development. He is actively guiding the company’s fundraising efforts and positioning it for growth.

Dragan Janković

Director of Engineering 

With over 20 years of experience, Dragan Janković has been instrumental in scaling medical device innovations globally. As a co-founder of LMB, he grew its Serbian team from 3 to 120, overseeing the development of 20+ medical devices. At Amnion Life, Dragan drives engineering and commercialization, supporting the advancement of neonatal technologies.

Dr. Emin Maltepe, M.D., Ph.D.

Senior Medical Advisor
Dr. Emin Maltepe, a neonatologist at UCSF, combines clinical practice with research in epigenetics and hypoxia. His work focuses on understanding fetal and placental development to address preterm birth complications. As a co-founder of IPD3, he advances pediatric drug and device development, aligning his expertise with Amnion Life’s mission to improve neonatal outcomes.

Global Reach and Collaborations

Amnion Life collaborates with leading hospitals, NICUs, and research institutions worldwide to advance neonatal care and address the critical challenges of preterm birth. With partnerships spanning North America, Europe, the Middle East, and Asia.